Prepair 500+
Gene: OPA3
Autosomal-recessive, relentlessly progressive neurodegenerative disease with 3-methylglutaconic aciduria that causes early-onset bilateral optic atrophy and late development of spasticity, extrapyramidal dysfunction and occasionally cognitive deficit.
AD form
Founder mutation in Iraqi Jews
HGNC approved symbol/name: OPA3
Is the phenotype(s) severe and onset <18yo? YCreated: 20 Jan 2025, 2:56 p.m. | Last Modified: 20 Jan 2025, 2:56 p.m.
Panel Version: 1.1235
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
3-methylglutaconic aciduria, type III MIM#258501; 3-methylglutaconic aciduria type 3 MONDO:0009787
Publications
Gene: opa3 has been classified as Green List (High Evidence).
Phenotypes for gene: OPA3 were changed from 3-methylglutaconic aciduria, type III, 258501 (3) to 3-methylglutaconic aciduria, type III MIM#258501; 3-methylglutaconic aciduria type 3 MONDO:0009787
Publications for gene: OPA3 were set to
gene: OPA3 was added gene: OPA3 was added to Prepair 500+. Sources: Mackenzie's Mission,Expert Review Green Mode of inheritance for gene: OPA3 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: OPA3 were set to 3-methylglutaconic aciduria, type III, 258501 (3)